Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y X Hu

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
European Review for Medical and Pharmacological Sciences|May 24, 2016
A prospective evaluation of minimal residual disease as risk stratification for CCLG-ALL-2008 treatment protocol in pediatric B precursor acute lymphoblastic leukemiaY-X Hu, J Lu, H-L He, et al.
European Review for Medical and Pharmacological Sciences|October 4, 2018
The therapeutic efficacy of pediatric ALL patients with MLL gene rearrangement treated with CCLG-ALL2008 protocolY-N Sun, Y-X Hu, L Gao, et al.
European Review for Medical and Pharmacological Sciences|September 20, 2018
Suppressed CCL2 expression inhibits the proliferation of leukemia cells via the cell cycle protein Cyclin D1: preliminary in vitro dataS-Y Wu, J Yang, D Hong, et al.
Physical Review Letters|May 15, 2026
Observation of Λ[over ¯]p→K^{+}π^{+}π^{-}π^{0} and Λ[over ¯]p→K^{+}π^{+}π^{-}2π^{0}M Ablikim, M N Achasov, P Adlarson, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
European Review for Medical and Pharmacological Sciences|May 24, 2016
A prospective evaluation of minimal residual disease as risk stratification for CCLG-ALL-2008 treatment protocol in pediatric B precursor acute lymphoblastic leukemiaY-X Hu, J Lu, H-L He, et al.
European Review for Medical and Pharmacological Sciences|October 4, 2018
The therapeutic efficacy of pediatric ALL patients with MLL gene rearrangement treated with CCLG-ALL2008 protocolY-N Sun, Y-X Hu, L Gao, et al.
European Review for Medical and Pharmacological Sciences|September 20, 2018
Suppressed CCL2 expression inhibits the proliferation of leukemia cells via the cell cycle protein Cyclin D1: preliminary in vitro dataS-Y Wu, J Yang, D Hong, et al.
Physical Review Letters|May 15, 2026
Observation of Λ[over ¯]p→K^{+}π^{+}π^{-}π^{0} and Λ[over ¯]p→K^{+}π^{+}π^{-}2π^{0}M Ablikim, M N Achasov, P Adlarson, et al.
Pageof 7